High-risk corneal allografts and why they lose their immune privilege

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 5, 2010, Pages 493-497

  Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Allergy; angiogenesis; corneal transplantation; immune privilege

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ALLERGY; ALLOGRAFT; ANTIGEN PRESENTING CELL; CD4+ CD25+ T LYMPHOCYTE; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CORNEAL TRANSPLANTATION; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; INFLAMMATION; MICE; NEOVASCULARIZATION, PATHOLOGIC; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956264366     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833dfa11     Document Type: Review

References (46)

1. George AJ, Larkin DF. Corneal transplantation: the forgotten graft. Am J Transplant 2004; 4:678-685.
2. Niederkorn JY. The immune privilege of corneal allografts. Transplantation 1999; 67:1503-1508.
3. Niederkorn JY. The immune privilege of corneal grafts. J Leukoc Biol 2003; 74:167-171.
4. Niederkorn JY. Immune mechanisms of corneal allograft rejection. Curr Eye Res 2007; 32:1005-1016.
5. Group CCTSR. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110:1392-1403.
6. Billingham RE, Boswell T. Studies on the problem ofcorneal homografts. Proc R Soc Lond B Biol Sci 1953; 141:392-406.
7. Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948; 29:58-69.
8. Bigger SL. An inquiry into the possibility of transplanting the cornea with the view of relieving blindness (hitherto deemed incurable) caused by several diseases of that structure. Dublin J Med Sci 1837; 11:408-447.
9. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg 1990; 21:781-785.
10. Williams KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: a new model. Invest Ophthalmol Vis Sci 1985; 26:23-30.
11. Niederkorn JY. The immunology of corneal transplantation. Dev Ophthalmol 1999; 30:129-140.
12. Niederkorn JY. Mechanisms of corneal graft rejection: The Sixth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group meeting, October 21, 2000. Cornea 2001; 20:675-679.
13. Niederkorn JY. Anterior chamber-associated immune deviation and its impact on corneal allograft survival. Curr Opin Organ Transplant 2006; 11:360-365.
14. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006; 7:354-359.
15. Niederkorn JY, Stein-Streilein J. History and physiology of immune privilege. Ocul Immunol Inflamm 2010; 18:19-23.
16. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3:879-889.
17. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 1993; 150:1727-1734.
18. Plskova J, Duncan L, Holan V, et al. The immune response to corneal allograft requires a site-specific draining lymph node. Transplantation 2002; 73:210-215.
19. Skelsey ME, Mellon J, Niederkorn JY. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 2001; 166: 4327-4333.
20. Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD-1d-reactive NKT cells. J Immunol 2002; 168:2028-2034.
21. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001; 42:1293-1298.
22. Chauhan SK, Saban DR, Lee HK, et al. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 2009; 182:148-153.
23. Albuquerque RJ, Hayashi T, Cho WG, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 2009; 15:1023-1030.
24. Cursiefen C, Chen L, BorgesLP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004; 113:1040-1050.
25. Cursiefen C, Chen L, Saint-Geniez M, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 2006; 103:11405-11410.
26. Dietrich T, Bock F, Yuen D, et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol 2010; 184:535-539.
27. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2:573-583.
28. El-Sawy T, Miura M, Fairchild R. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol 2004; 165:147-157.
29. Fairchild RL, VanBuskirk AM, Kondo T, et al. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 1997; 63:1807-1812.
30. Hancock WW, Wang L, Ye Q, et al. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003; 15:479-486.
31. Kondo T, Novick AC, Toma H, et al. Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 1996; 61:1750-1757.
32. Miura M, El-Sawy T, Fairchild RL. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol 2003; 162:509-519.
33. Miura M, Morita K, Kobayashi H, et al. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 2001; 167:3494-3504.
34. Morita K, Miura M, Paolone DR, et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001; 167:2979-2984.
35. Amescua G, Collings F, Sidani A, et al. Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. Transplantation 2008; 85:615-625.
36. Beauregard C, Stevens C, Mayhew E, et al. Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol 2005; 174:6577-6581.
37. Flynn TH, Ohbayashi M, Ikeda Y, et al. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea. Invest Ophthalmol Vis Sci 2007; 48:4044-4049.
38. HargraveSL, HayC, Mellon J, et al. Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci 2004; 45:1188-1193.
39. Niederkorn JY, Chen PW, Mellon J, et al. Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and Th2 alloimmune responses. J Immunol 2010; 184:6076-6083.
40. Niederkorn JY, Chen PW, Mellon J, et al. Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transplant 2009; 9:1017-1026.
41. Ghoraishi M, Akova YA, Tugal-Tutkun I, et al. Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 1995; 14:610-613.
42. Hargrave S, Chu Y, Mendelblatt D, et al. Preliminary findings in corneal allograft rejection in patients with keratoconus. Am J Ophthalmol 2003; 135:452-460.
43. Lyons CJ, Dart JK, Aclimandos WA, et al. Sclerokeratitis after keratoplasty in atopy. Ophthalmology 1990; 97:729-733.
44. Dahl ME, Dabbagh K, Liggitt D, et al. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5:337-343.
45. Randolph DA, Stephens R, Carruthers CJ, et al. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999; 104:1021-1029.
46. Stern ME, Siemasko K, Gao J, et al. Role of interferon-gamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2005; 46:3239-3246.